Alphanate Articles

PPL reports flat income for full-year 2003

10 May 2004

Tercica gets rights to rhIGF-I from Fujisawa

10 May 2004

NPS and Nycomed sign Preos deal

26 April 2004

ZymoGenetics' thrombin in Ph II

26 April 2004

FDA clears Aventis' insulin Apidra

26 April 2004

Halozyme in manufacturing deal with Avid Bioservices

19 April 2004

Unigene in calcitonin deals with Novartis

19 April 2004

Positive Phase III results for NPS' Preos

5 April 2004

Serono's Serostim helps lean body mass

5 April 2004

Dragon to merge into Oriental Wave

5 April 2004

Bayer posts worst loss in history but predicts a turn around

29 March 2004

Xoma sees net loss jump as revenues fall

22 March 2004

Merck KGaA focuses on therapies for cancer, CVD, diabetes and thyroid

15 March 2004

Serologicals expands distribution deal with Novo Nordisk

15 March 2004

Serono's Gonal-f pre-filled pen gets OK from EC

8 March 2004

Ph IIa results for Dyax' DX-890

1 March 2004

UK NHS to offer free IVF treatment

1 March 2004

NovoSeven cleared in EU for two new uses

1 March 2004

Novartis' Slovenian subsidiary Lek boosts biopharma activity

23 February 2004

Affitech gets FUGE grant for new cancer drug

23 February 2004

Novo Nordisk profits up 19% in 2003

16 February 2004

Nuvelo licenses novel anticoagulant

16 February 2004

Novartis' Sandoz unit completes new production facility in Austria

9 February 2004

GTC Bio restructures to support programs

9 February 2004

Alexion's eculizumab shows mixed results for RA but promise for PNH

9 February 2004

S-P launches Rebetol oral solution in USA

26 January 2004

Corixa and GSK to start trial for TB vaccine

26 January 2004

BioSante gets DynPort anthrax subcontract

19 January 2004

Avid Bio expands capacity

5 January 2004

Xoma/Millennium's MLN2222 enters Ph I

5 January 2004

Roche signs Japanese deal with Chugai

22 December 2003

HIV vaccine begins small-scale clinical trial in Belgium

22 December 2003

Generex initiates feasibility study on rHGH

15 December 2003

Bayer sees 3rd-qtr loss and settles for a "mid-size Euro pharma" image

17 November 2003

Positive long-term findings for Aryplase

17 November 2003

Serono beats expectations with 3rd-qtr 2003 net income up 48%

3 November 2003

Improving the treatment of anemia in cancer, discussed at ECCO

20 October 2003

BioProtein to milk platform technology following extension

20 October 2003

Positive news for Serono's Luveris

13 October 2003

Meridian Bioscience gains NIH award for Parvovirus vaccine

13 October 2003

ZymoGenetics deal with Abbott on human Thrombin

13 October 2003

PPL Therapeutics to sell business after key investors lose faith

22 September 2003

First approval of Berna Biotech's hep B vaccine

15 September 2003

Ipsen and Octagen start Ph I for OBI-1

15 September 2003

Dutch biotech Crucell hires US investor relations firm

8 September 2003

Schering AG's Leukine may compensate for Yasmin generics, says Morgan Stanley

4 August 2003

FDA approves Baxter hemophilia drug

4 August 2003

Serono raises 2003 forecast; 2nd-qtr figs

4 August 2003

Meridian to make/ distribute Corixa Chagas' proteins

28 July 2003

UK biotech sector still lagging behind US; investors push for consolidation

28 July 2003

Tokyo pharma stocks - week to July 14

21 July 2003

XOMA closes license deal with Baxter

14 July 2003

India: Phase III trials for biotech imports

14 July 2003

Novo Nordisk's Norditropin cleared by EC

7 July 2003

Vaxgen opens new facility in California

30 June 2003

Italy seeks US aid over Pompe disease

30 June 2003

Bio-Tech General changes name to Savient

23 June 2003

Tokyo pharma stocks - week to June 16

23 June 2003

Genzyme's Myozyme begins Pompe study

9 June 2003

EPO boosts Dragon Pharma revenues

9 June 2003

Modest growth for Ipsen in 2002

2 June 2003

1st-qtr results for France's Transgene

12 May 2003

China fast-tracks SARS Rx approvals, imports

12 May 2003

Losses widen at PPL in 2002 as firm refocuses

5 May 2003

Serono

5 May 2003

Serono to invest $5.4M in SPain

21 April 2003

Medtronik/Wyeth's rhBMP-2 device cleared in Canada

14 April 2003

Aventis Behring CEO urges joint effort to boost plasma protein ind

7 April 2003

TKT gets two US gene therapy patents

31 March 2003

Baxter International's financial picture still a liquid situation, says broker

31 March 2003

New use for Norditropin backed in EU

31 March 2003

Beaufour gets EU Ok for Nutropin AQ

24 March 2003

Bayer sees growth for 2003 operating results; Baycol lawsuits increase

24 March 2003

Vical to trial anthrax vaccine by year end

17 March 2003

4th-qtr charges hit Genzyme General

17 March 2003

Baxter, Arriva trial rec alpha-1 antitrypsin

10 March 2003

Baxter gains major Canadian blood product contract

10 March 2003

Chiron to start Phase III trial of meningitis C vaccine in USA

10 March 2003

NPS Pharma and Enzon to merge in $1.6B deal; aim to be "a new biotech leader"

3 March 2003

Virax shares slump as HIV trial disappoints

24 February 2003

Study questions long-term IFN use in MS

24 February 2003

J&J confirms $2.4 billion offer for Scios

17 February 2003

2002's crop of new product launches backs up R&D fears

10 February 2003

IVAX to develop new HIV approach

10 February 2003

Wockhardt to launch Indian insulin product

10 February 2003

Wyeth licenses VSV patents to GTx

3 February 2003

Amgen's mucositis drug clears Phase III trial

3 February 2003

GeoVax HIV vaccine heads for trials

3 February 2003

LSBC's plant-based Fabry drug gets orphan status in USA

27 January 2003

Genzyme scores second victory with FDA panel endorsement of Aldurazyme

20 January 2003

NeuTec reports progress in Ph II trial of Aurograb for MRSA infections

20 January 2003

BioPartners, Rentschler to take on MS market

20 January 2003

Blow for ICOS as sepsis drug fails in Phase III

6 January 2003

DSM Biologics signs up with Crucell

6 January 2003

BioMarin's loss grows

19 August 2002

Dendreon cancer vaccine misses endpoint, but company stays positive

19 August 2002

ZymoGenetics net loss up 55% in 2nd qtr

19 August 2002

Repligen revenues up 127% in 2nd quarter

12 August 2002

Emisphere/Lilly trial oral hGH product

12 August 2002

CeNeS Pharmaceuticals reports identification of a risk gene for

5 August 2002

Showing 601-700 of 1792 articles

Go to beginningPreviousNextGo to end